Immunovant (IMVT) Current Taxes (2019)

Immunovant's (IMVT) quarterly Current Taxes came in at $106000.0 in Q4 2019, up 236.4% on a QoQ basis from $31510.0 in Q3 2019.

Immunovant (IMVT) Current Taxes (2019) Analysis & Trends

Immunovant (IMVT) has 1 years of Current Taxes data on file, last reported at $106000.0 in Q4 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 49.00 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 76.32 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 59,089.99
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Immunovant 8.63 Bn 7.83 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2019 106,000.00
Sep 30, 2019 31,510.00
Jun 30, 2019 66,467.00